Sponsor
Esperante Development B.V.
Tolweg 15, 3741 LM, The Netherlands
About the sponsor
Research activity is centered on bioequivalence evaluation for orally administered medicines under fasting conditions, with attention to comparing a developed tablet formulation against an established reference product.
- Betahistine dihydrochloride tablets
- Reference-comparator medicine assessment
- Oral solid dosage forms
The sponsor’s clinical interest is focused on therapeutic equivalence in otology-related treatment, particularly medicines used in vestibular disorders and vertigo management.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.